Search

everythinglearnresearchcommunity

for

Search:↓

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

Topical anthralin helped regrow hair in mice with a condition similar to human alopecia.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Mast cells might contribute to hair loss by causing skin thickening.

Women with early onset androgenetic alopecia have worse lipid profiles.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

Melanocytes produce melanin; their defects cause vitiligo and hair graying, with treatments available for vitiligo.

Systemic corticosteroids help manage vitiligo by slowing progression and aiding repigmentation.

CCCA and LPP may be related hair loss conditions influenced by genetics and environment, needing early treatment.

The review emphasizes the need to recognize skin conditions that affect hair follicles and sweat glands to avoid misdiagnosis.

Topical treatments led to hair regrowth in a man with linear morphea.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Benign skin tumors need accurate diagnosis to ensure proper treatment.

Estrogen increases a growth factor in hair cells which might affect hair loss.

Mast cells play a significant role in hair loss conditions like male pattern hair loss and alopecia areata.

Finasteride helps female-pattern hair loss.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

A combined treatment with microneedling and vitamin D3 led to complete hair regrowth in a woman with stubborn patch alopecia areata.

Key genes linked to immune response are upregulated in hair follicles and skin tissues in chronic discoid lupus erythematosus.

Key genes linked to immune response are highly active in lupus-affected hair follicles.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Diphencyprone helped most patients with alopecia areata regrow some hair.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

Liquid nitrogen cryotherapy and betamethasone lotion are equally effective for treating alopecia areata.

Pregnancy right after giving birth in mice lacking IL-10 causes milk that leads to liver issues and hair loss in their babies.

Disrupted cysteine metabolism may cause hair breakage in Alopecia Areata, suggesting potential treatments like N-acetylcysteine.

Topical corticosteroids are the preferred first treatment for children with Alopecia Areata.